Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)

Last updated: October 25, 2024
Sponsor: University of California, Los Angeles
Overall Status: Active - Recruiting

Phase

N/A

Condition

Pneumonia

Nephritis

Soft Tissue Infections

Treatment

Next Day Clinic

Clinical Study ID

NCT06526884
24-000913
  • Ages > 18
  • All Genders

Study Summary

The Next Day Clinic (NDC) is a quality improvement initiative that will be launched and operated by UCLA Health starting July 22, 2024. Its goals are to improve patient care and safety and to maximize cost effectiveness. The way it does this is by identifying patients in the ED who would normally be admitted for low-acuity conditions, and diverting them to a high-acuity clinic the following day called the NDC. This will help decompress the ED and the hospital, and allow for overall higher quality care. The Health System has partnered with UCLA's Healthcare Value Analytics and Solutions [UVAS] group which specializes in these types of program evaluations. The analysis conducted by the study team will be used to directly inform NDC operations, scaling, and future plans.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • 18 years of age or older

  • About to be admitted through the ED for one of the NDC diagnoses or a synonym (perStudy Protocol document), defined by the presence of a Plan to Admit order or BedRequest order, OR recently admitted under observation or inpatient status for one ofthe NDC diagnoses.

  • Identified as at-risk for an avoidable hospitalization in the ED based on apre-determined set of lab and vital parameters.

  • Insurance that authorizes the patient to follow-up at UCLA Health, or self-pay

  • Admitted or being admitted to an internal medicine service

Exclusion

Exclusion Criteria:

  • Heart or lung transplant recipient with concern for graft dysfunction

  • Pregnant

  • Enrolled in hospice

  • Resides in or discharged to a skilled nursing facility/acute rehabilitation facility

  • Admitted to a critical care service

  • ED deems discharge unsafe due to complex social or medical factors

  • Active malignant cancer (per Council of State and Territorial Epidemiologists valueset)

  • Pulmonary arterial hypertension (per Joint Commission value set)

  • Undergoing workup for solid organ transplant

  • Interstitial lung disease (including pulmonary fibrosis) (per Higher Level 7 valueset)

  • Requiring inpatient procedure or surgery defined by the presence of an anesthesiaevent or operating room encounter.

  • The ED deems discharge unsafe due to complex social or medical factors.

  • Transferred to an ineligible hospital

Note:

The Health System plans to limit the volume of referrals to the NDC by only referring patients who have an even birth date (this is more equitable than first-come-first-serve, because wage workers are more likely to come to the ED later in the day; even/odd birth date theoretically keeps more spots open for patients presenting to the ED later).

Study Design

Total Participants: 1080
Treatment Group(s): 1
Primary Treatment: Next Day Clinic
Phase:
Study Start date:
July 22, 2024
Estimated Completion Date:
November 30, 2025

Study Description

NDC is a hospital avoidance model with the potential to simultaneously improve the quality and safety of acute care, reduce costs, and address hospital/ED overcrowding. This novel hospital avoidance program will divert patients from the ED who have been diagnosed with the following conditions and meet certain clinical criteria:

  • Diabetic Foot Infection/Osteomyelitis

  • Cellulitis

  • Congestive Heart Failure

  • Syncope

  • Pyelonephritis/Urinary Tract Infection

  • Pneumonia

  • Acute Kidney Infection

Connect with a study center

  • Ronald Reagan UCLA Medical Center

    Los Angeles, California 90024
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.